AMU, AP-HM, CIML, INNATE PHARMA
Marseille Immunopole is born from the will of all partners to do even better and progress faster, and thus allow patients always to keep one step ahead of the disease.
At the end of 2013, Science Magazine designated immunotherapy as the major medical breakthrough of the year. Since then, the success of this new anti-cancer weapon has not been contradicted and tomorrow patients with inflammatory diseases should, in turn, benefit from this approach.
Today, our city is at the forefront of this revolution. Together, Marseille researchers, physicians and industry leaders have contributed and still contribute to the discovery, development and clinical evaluation of immunotherapy antibodies. They also develop diagnostic tools that should allow customisation of these drugs and an approach that many consider the next frontier of immunotherapy: cell therapies.
With my colleagues, I have already participated in the first part of this adventure: CIML contributed to NK immunotherapy developed by Innate Pharma, I myself cofounded the company in 1999 and created a laboratory at the Conception Hospital dedicated to the exploration of these lymphocytes. Lastly, with other immunology teachers of Aix-Marseille University, we also provide research, clinics and industry with new talents.
Marseille Immunopole is born from the will of all partners to do even better and progress faster, and thus allow patients always to keep one step ahead of the disease.#clinique #industrie #recherche
MI carries a strong voice for immunology research, freeing partners from their public or private sectors, breaking down disciplinary barriers and creating the essential conditions for acting together, quickly and sustainably
Thanks to this unprecedented alliance of researchers, clinicians, technological platforms and industrials we should be able to quickly do much better
Unique cluster in the world exclusively dedicated to basic and applied immunology, MI results from an efficient territorial game between research, industry, and the institutional stakeholders in economy and innovation.
CCI Marseille Provence
MI is a diamond of the new Metropolis, offering a unique opportunity to drive science forward and provide more effective therapeutic options for our cancer patients.